←
ed silverman282 posts
ed silverman avatar

ed silverman

@edsilverman

Pharmalot columnist and senior writer at @STATnews.. former WSJer.. proud dad; likes music, dogs and taking naps

◷ Joined November 2008▧ 1 Photos and videos
ed silverman avatar
ed silverman@edsilverman·5 Jun 2024

Student group that ranked med schools over industry conflicts votes to accept pharma funding.. statnews.com/pharmalot/2024/… #pharma #medicine #MedicalEducation #medschool #conflicts

ed silverman avatar
ed silverman@edsilverman·25 Apr 2024

““The whole purpose of biosimilars was to introduce competition into the marketplace," said study author Ben Rome. "...The fact that it’s so hard to find savings consistently is disappointing." statnews.com/pharmalot/2024/… #pharma #biotech #biologics #biosimilars #medicines

ed silverman avatar
ed silverman@edsilverman·25 Apr 2024

“Colombia is planting a flag for global health equity,” said Peter Maybarduk of Public Citizen. “This will inspire new challenges to patent barriers and improve treatment access, towards an AIDS-free generation." statnews.com/pharmalot/2024/… #patents #medicines #Colombia #HIV $GSK

ed silverman avatar
ed silverman@edsilverman·21 Mar 2024

“The messages are filled with misinformation that is hard to set straight because it is such a complicated topic and patients are made to feel like their lives are at stake" statnews.com/pharmalot/2024/… #pharma #RareDiseases #medicines #drugs #Colorado #Enbrel $AMGN $VRTX

ed silverman avatar
ed silverman@edsilverman·30 Jan 2024

CMS will use outcomes-based agreements in bid to help Medicaid pay for sickle cell gene therapies.. statnews.com/pharmalot/2024/… #pharma #Medicaid #CMS #medicines #sicklecell $VRTX $CRSP $BLUE

ed silverman avatar
ed silverman@edsilverman·24 Jan 2024

When it comes to policing pharma, the FTC says it’s on ‘an incredible winning streak’.. statnews.com/pharmalot/2024/… #pharma #FTC #antitrust #monopoly #Biden #rebates #patents #mergers $CVS $AMGN $UNH $CI $GSK $AZN $SNY

ed silverman avatar
ed silverman@edsilverman·18 Dec 2023

‘We’ve exhausted all avenues’: A small biotech may give up on its ultra-rare disease drug over frustration with FDA.. statnews.com/pharmalot/2023/… #pharma #biotech #FDA #raredisease #orphandrug

ed silverman avatar
ed silverman@edsilverman·5 Oct 2023

Was Amgen less than forthcoming about FDA’s concerns on its cancer drug?.. my latest column.. feedback, suggestions, criticism are welcome.. statnews.com/2023/10/04/amge…… #pharma #biotech #cancer #FDA #transparency #clinicaltrials $AMGN

ed silverman avatar
ed silverman@edsilverman·4 Oct 2023

Colombia set to issue a compulsory license for an HIV medicine sold by GSK’s ViiV.. statnews.com/pharmalot/2023/… #pharma #patent #HIV #AIDS #Colombia $GSK $PFE

ed silverman avatar
ed silverman@edsilverman·29 Jun 2023

Drug wholesaler owner indicted for alleged role in diverting Gilead and J&J HIV medicines.. read the indictment here.. statnews.com/pharmalot/2023/… #pharma #HIV #counterfeit $GILD $JNJ

ed silverman avatar
ed silverman@edsilverman·29 Jun 2023

SEC charges former Pfizer statistician with insider trading over Paxlovid clinical trial results.. statnews.com/pharmalot/2023/… #pharma #SEC #insidertrading #Paxlovid $PFE